Related Experiment Video
Updated: May 25, 2025

00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
Designing a Patient Preference Study on Subcutaneous Medical Devices: Incorporating Health Authority Scientific
Marie Picci1, Nigel S Cook1, Byron Jones2
1Novartis Pharma AG, Basel, Switzerland.
Therapeutic Innovation & Regulatory Science
|February 26, 2025
Summary
This study planned a patient preference evaluation for subcutaneous drug delivery devices. It focused on understanding what Multiple Sclerosis patients value in high-volume injection devices.
Area of Science:
- Pharmacology
- Biomedical Engineering
- Patient-Reported Outcomes
Background:
- Subcutaneous (SC) drug delivery is evolving for high-volume (e.g., >2 mL) medications.
- Patient preferences are crucial for the adoption and usability of novel medical devices.
- Understanding patient needs informs the design of effective drug administration technologies.
Purpose of the Study:
- To describe the planning of a patient preference study.
- To evaluate device features for high-dose, large-volume SC drug delivery.
- To identify key attributes important to Multiple Sclerosis (MS) patients for SC administration devices.
Main Methods:
- Qualitative patient interviews were conducted.
- Patient partners were involved throughout the planning process.
- Advice was solicited from the US Food and Drug Administration (FDA).
- Study attributes and levels were refined based on multiple input sources.
Main Results:
- A robust protocol for a patient preference study was developed.
- Key device features important to MS patients for high-dose SC administration were identified.
- The study design incorporates patient-centricity and regulatory input.
Conclusions:
- The planned study will provide valuable insights into patient preferences for SC drug delivery devices.
- This research supports the development of user-centered medical devices for chronic disease management.
- Incorporating patient and regulatory feedback is essential for successful medical device development.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Study Designs in Epidemiology
159
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
159

